|
Teva Announces European Medicines Agency (EMA) Confirms Successful Validation …
MarketWatch “Uncontrolled asthma remains a serious challenge for patients and healthcare professionals despite the availability of standard of care treatment,” said Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical … |
View full post on asthma – Google News